The study builds on Dr Elias Sayour’s (University of Florida) earlier research and marks a key step toward a universal cancer vaccine that boosts immunotherapy’s effectiveness.

CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the Company’s investigational ...

Analysts are expecting Moderna to report revenue of $880 million in the third quarter, according to FactSet. The consensus ...

Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

For patients with certain types of advanced lung or skin cancer, administration of SARS-CoV-2 mRNA vaccine within 100 days of starting ICIs is associated with increased overall survival.

A study conducted by a multinational research group investigated the potential of audible sound waves (in the form of music, specifically Pink Floyd’s "Another Brick in the Wall, Part 1") in enhancing ...

Vaccine manufacturing is challenged by stringent global regulations, essential for ensuring safety and efficacy, with ...

What if the brain's response to stress could be read not in fleeting neurotransmitter bursts, but in the quieting of genes deep inside chromatin? Researchers at the University of Alabama at Birmingham ...

Strand Therapeutics promotes Prashant Nambiar to CSO and appoints Ethan Cash as SVP, Head of Portfolio Management and Program ...

Lipid-based nanoparticles are pivotal in modern medicine, improving drug delivery and mRNA therapies through innovative ...

The department said Suzman’s participation highlights the foundation’s long-standing partnership with Biovac and commitment ...